Clinical Trial Update: VERifynow in DIabetes Non-responsiveness: a Study on Switching From Clopidogrel to Prasugrel [Phase 4]

View source ↗

Summary

Completed Phase 4 study evaluating switching from clopidogrel to prasugrel in patients with type 2 diabetes mellitus and acute coronary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Diabetes Mellitus Type II, Acute Coronary Syndrome | Phase 4 | Status: COMPLETED